Affinity purification and identification of unique, shared, anti-IA-2 B cell clonotypes: A proteomic approach to understanding the pathophysiological mechanisms underpinning autoimmunity in Type 1 diabetes

Author: Thilini Mendis

Mendis, Thilini, 2023 Affinity purification and identification of unique, shared, anti-IA-2 B cell clonotypes: A proteomic approach to understanding the pathophysiological mechanisms underpinning autoimmunity in Type 1 diabetes, Flinders University, College of Medicine and Public Health

Terms of Use: This electronic version is (or will be) made publicly available by Flinders University in accordance with its open access policy for student theses. Copyright in this thesis remains with the author. You may use this material for uses permitted under the Copyright Act 1968. If you are the owner of any included third party copyright material and/or you believe that any material has been made available without permission of the copyright owner please contact copyright@flinders.edu.au with the details.

Abstract

Type 1 diabetes is characterised by the loss of pancreatic beta cells. Research suggests that the clinical onset of type 1 diabetes occurs due to islet autoimmunity, which is reflected by the presence of autoantibodies to various islet antigens, including Islet antigen 2 (IA-2A). Antibodies against pancreatic IA-2 is associated with rapid disease progression and are a readily used diagnostic marker which is found in about 80% of newly diagnosed T1D patients.

The aim of my study was to examine self-reactive clonotypic IA-2 autoantibodies isolated from sera of patients with type 1 diabetes in order to see any correlations in gene usage between patients. Providing insights into pathogenic pathways in type 1 diabetes and therapeutic approaches to address the disease process.

Keywords: Autoimmunity, Type 1 diabetes, IA-2, autoimmune diabetes, organ-specific autoimmune disease

Subject: Public Health thesis

Thesis type: Doctor of Philosophy
Completed: 2023
School: College of Medicine and Public Health
Supervisor: Dr. Michael Jackson